Biography:
Mayra Ramos Suzarte has completed her PhD at the age of 33 years from Havana Medical University and postdoctoral studies from Modena University, Oncological Medical Center, Italy and Las Condes Hospital Chile. She is the Head of Clinical trials Department at the Center of Molecular Immunology, Cuba since 2009. She has published more than 80 papers, and four books in reputed journals and has been serving as an editorial board member of repute, participated in more than 70 Conferences.
Title : Observational study post emergency use authorization of itolizumab in the treatment of COVID-19
Title : Vaccines and monoclonal antibodies in the prolonged treatment of non-small cell lung cancer: 20 years of follow-up
Title : Therapeutic repositioning of the monoclonal antibodies itolizumab and nimotuzumab in COVID-19.